Centrum Medyczne Amed Sp. z o.o.

At Centrum Medyczne Amed Sp. z o.o. in Warsaw, clinical research in cardiovascular disease and nutritional and metabolic disease focuses on improving care for people with atherosclerotic heart and blood vessel disease and type 2 diabetes mellitus. These studies are designed to evaluate whether new approaches can better reduce cardiovascular risk, support blood sugar management, and improve the overall effectiveness of treatment.

• Testing new ways to lower the risk of major cardiovascular events in people with established artery disease
• Assessing decentralized and hybrid trial models to improve recruitment, retention, and participant experience in type 2 diabetes research
• Evaluating whether current lipid-lowering treatment strategies can be improved for patients with persistent atherosclerotic cardiovascular disease

This area combines treatment evaluation with practical research on how trials can be made more accessible and efficient for participants.

The site also supports research in immune system diseases and immune system processes, with a strong focus on psoriatic arthritis, rheumatoid arthritis, and primary Sjögren's syndrome. These trials are exploring whether newer therapies can better control inflammation, ease symptoms, and maintain long-term safety in chronic autoimmune conditions.

• Comparing treatment options for active psoriatic arthritis to see which may provide better symptom control
• Studying long-term safety and tolerability in adults living with psoriatic arthritis
• Evaluating sustained safety in patients with primary Sjögren's syndrome
• Investigating therapies for rheumatoid arthritis to improve day-to-day disease management

This research reflects a broad effort to advance both symptom relief and long-term treatment confidence in autoimmune care.

Several trials at this Warsaw site are centered on psoriatic arthritis, including active and axial forms of the disease. The goal is to test new therapies and compare them with existing options to understand how well they reduce joint pain, stiffness, and broader inflammatory symptoms.

• Evaluating whether emerging treatments can improve outcomes in active psoriatic arthritis
• Assessing relief of axial symptoms in people with psoriatic arthritis affecting the spine
• Monitoring the longer-term safety of treatments used for chronic inflammatory joint disease

This focused program highlights the site’s role in advancing care for complex inflammatory arthritis.